OpGen could sell up to $37.4 million of shares in initial public sale

Bookrunner Maxim helps fund sales, marketing, research and development

By Devika Patel

Knoxville, Tenn., March 3 – OpGen, Inc. will price its initial public offering of common stock with a greenshoe, according to a Form S-1 filed Tuesday with the Securities and Exchange Commission. The company has registered up to $37.4 million of stock.

Maxim Group LLC is the bookrunning manager.

Proceeds will be used for sales and marketing, research and development and working capital purposes.

The Gaithersburg, Md., company uses molecular testing and bioinformatics to help combat multi-drug-resistant bacterial infections. It expects its shares to trade on the Nasdaq exchange under the symbol “OPGN.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.